Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Data-driven miRNA classifier as response predictor for immune checkpoint inhibitor treatment in advanced-stage cancer patients


24 Nov 2019


Mini Oral session - Immunotherapy of cancer


Chia-Hsun Hsieh


Annals of Oncology (2019) 30 (suppl_9): ix107-ix114. 10.1093/annonc/mdz438


C. Hsieh1, S. Kang2, W. Chen2, Y. Lin1, H. Wang3, J. Chen1, Y. Hsieh2, E.P. Yang2

Author affiliations

  • 1 Hematology-oncology, Chang Gung Memorial Hospital, 333 - Taoyuan/TW
  • 2 Business Development, Quark Biosciences, Inc., 30261 - Hsinchu City/TW
  • 3 Oncology, Chang Gung Memorial Hospital, 333 - Taoyuan/TW


Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings